Literature DB >> 29243552

Is it possible to draw firm conclusions from the PLIANT trial?

Jan Olof G Karlsson1, Per Jynge1.   

Abstract

Year:  2017        PMID： 29243552     DOI： 10.1080/0284186X.2017.1416167

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  2 in total

Review 1.  Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics-A Review.

Authors:  Jelena S Katanic Stankovic; Dragica Selakovic; Vladimir Mihailovic; Gvozden Rosic
Journal:  Int J Mol Sci       Date:  2020-10-20       Impact factor: 5.923

2.  The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOx.

Authors:  Jan Olof G Karlsson; Per Jynge; Louis J Ignarro
Journal:  Antioxidants (Basel)       Date:  2021-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.